In the second part, the discussion turns to emerging DED therapies that target tear function and ocular surface homeostasis.
In-office application of a double layered amniotic membrane is well-tolerated and effective for ocular surface diseases, a case series shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback